The UK Cosmetics Regulation governs cosmetic products sold in Great Britain (England, Scotland, and Wales) following Brexit, retained in UK law and amended by Schedule 34 of the Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019 and subsequent statutory instruments.
Under the technical wording, the UK kept the architecture of EU Regulation 1223/2009 while running its own enforcement, its own notification portal, its own Responsible Person framework, and an increasingly independent ingredient-control process.
Brexit duplicated the cosmetic rules rather than rewriting them.
Products sold in Great Britain need a UK-based Responsible Person, a UK-specific Product Information File, a Submit Cosmetic Product Notification (SCPN) filing, and UK-compliant labeling. Northern Ireland continues to follow EU rules under the Windsor Framework.
After 30 years in the hair and beauty sector, most recently in private label cosmetics, the UK compliance path is where I see the most shortcuts taken.
For the broader global compliance picture and the EU framework, see those guides.
Important disclaimer: I am not a lawyer or UK regulatory professional. This is practical industry perspective, not legal advice. For specific questions, work with a qualified UK regulatory consultant.
This guide covers the post-Brexit framework, the UK Responsible Person, SCPN notification, Northern Ireland, the 2026 ingredient bans, and practical implications.
UK compliance in 2026 starts with the legal structure that replaced EU jurisdiction.
At the end of the Brexit transition period on December 31, 2020, the EU Cosmetics Regulation 1223/2009 ceased to apply directly in Great Britain. In Northern Ireland it continues to apply.
Its substance was retained in UK law through Schedule 34 of the Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019. Since then, this body of law, commonly called the UK Cosmetics Regulation or UKCR, has been amended by a series of statutory instruments issued by the UK government.
The competent authority for Great Britain is the Office for Product Safety and Standards (OPSS), part of the UK Department for Business and Trade (DBT).
OPSS operates enforcement through local Trading Standards officers, who have inspection and seizure authority at retail and distribution level.
The structural architecture of UK cosmetic regulation remains recognizably the same as EU 1223/2009.
Product safety requirement. Cosmetics must be safe for human health under normal or reasonably foreseeable conditions of use. The safety standard is substantively identical to EU Article 3.
Responsible Person requirement. Every product needs a Responsible Person, now based in the UK, who holds legal compliance liability.
Product Information File requirement. Each product needs a PIF maintained by the Responsible Person, accessible to OPSS on request.
The retention period is 10 years after the last batch is placed on the market.
Cosmetic Product Safety Report requirement. The PIF must contain a CPSR structured along the same Annex I architecture as the EU version, signed by a qualified safety assessor.
Pre-market notification requirement. Every product must be notified before being placed on the market, now through SCPN instead of CPNP.
Labeling architecture. Ingredient declaration in INCI, function statement, net quantity, batch identifier, minimum durability or PAO, warnings where required, Responsible Person name and address, all fundamentally aligned with EU practice.
Several specific elements have changed since Brexit.
Responsible Person location. Must be established in the UK. An EU Responsible Person cannot cover the Great Britain market.
Notification portal. SCPN replaces CPNP with separate filing, separate credentials, and a separate reference number.
Scientific advisory body. In March 2021, the UK established its own Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products (SAG-CS).
This body took over the role of the EU’s SCCS for UK-specific ingredient evaluations.
Amendment cycle. EU amendments to Regulation 1223/2009 are not automatically applied in Great Britain; in Northern Ireland they apply as they always did, because the Regulation is still in force there. Each Great Britain update requires its own statutory instrument. This is why the Great Britain and EU prohibited-substance lists have started to diverge since 2021.
Labeling specifics. Great Britain labels must use a UK address for the Responsible Person. For imported products the label must specify the country of origin.
Enforcement regime. UK Cosmetic Products Enforcement Regulations 2013 define penalty ranges, inspection powers, and Trading Standards enforcement pathways. Breaching one of the cosmetics articles listed in Schedule 4 of those Regulations is a criminal offence in itself, with no threshold of seriousness or repetition. Penalties are in the FAQ below.
A single EU dossier does not cover Great Britain.
A brand selling in both markets operates in parallel.
Two Responsible Persons, two PIFs (with almost identical content but formally separate), two notifications, two sets of labels with different Responsible Person addresses, and two regulatory contacts to maintain.
The content overlap is high, but the legal separation is complete.
Under UK Cosmetics Regulation Article 4, every cosmetic product placed on the GB market must have a designated UK Responsible Person.
The UK RP must be a legal or natural person established in the United Kingdom, whose name and UK address appear on the product label. For brands based in the UK, this can be the brand itself. For brands based outside the UK (including EU brands), a UK-based RP must be contracted.
The UK RP’s responsibilities mirror the EU RP framework but apply to UK regulatory obligations.
Submit the SCPN notification before the product is placed on the GB market. Hold the UK Product Information File and maintain it throughout the product lifecycle plus 10 years after the last batch placement. Ensure the CPSR meets UKCR Annex 1 requirements and is signed by a qualified safety assessor, and that the product label complies with UKCR requirements (UK address, UK-specific declarations where applicable). Respond to OPSS safety queries and cooperate with Trading Standards inspections. Report serious undesirable effects to OPSS when they occur.
The commercial UK RP service market is mature.
A brand launching in the UK can contract with specialized firms that offer UK RP representation alongside SCPN notification, PIF management, and compliance monitoring.
Typical UK RP service costs run 500 to 2,000 GBP per year (roughly equivalent in EUR/USD at current rates) for a small brand catalog, similar in structure to the EU RP service market. (All cost figures in this article are indicative estimates that vary by provider, region, and project scope.)
Some firms charge per-product fees for SCPN filings and PIF updates on top of the annual base.
Before contracting a UK RP, verify their actual UK establishment (registered office, physical presence, not just a mailing address), their regulatory experience and OPSS interaction history, their PIF management system and retention capability, and the specific scope of services included in the base fee versus add-on charges.
A brand I worked with in 2024 contracted a "UK Responsible Person" service through what turned out to be a forwarding address with no actual regulatory capability behind it. When OPSS sent a routine query, it sat unanswered for weeks. The RP was nominally in place but operationally absent. The brand had to urgently contract a real RP, transfer the PIF, and re-notify through SCPN under its own reference. Cheap UK RP services are not always RP services at all.
Budget appropriately and verify the UK RP’s actual capability before signing.
The UK RP is your compliance infrastructure in the market, not a mailbox.
The Submit Cosmetic Product Notification portal is the UK government online system where the UK RP notifies each cosmetic product before it is placed on the Great Britain market.
Purpose. The SCPN fulfills the pre-market notification requirement under UKCR.
It also provides composition data to UK poison centres and NHS medical response teams for emergency use.
Access. Only UK RPs can submit SCPN notifications. Access is set up through OPSS account registration, typically processed within a few business days.
Required information. Category and physical form of the product, trade name, brand, and product identification, packaging type, UK RP name and address, frame formulation or full composition, CMR substance declarations, nanomaterial declarations (with additional notification requirements parallel to EU Article 16), label artwork upload, and packaging photograph.
SCPN reference number. Once the notification is submitted, the portal generates a unique SCPN notification number. This number functions as proof of notification and is requested by UK retailers, marketplaces, and customs in compliance verification.
Maintenance. The UK RP must update the SCPN notification without delay when product information or ingredient composition changes.
Under the Windsor Framework, which is the name the EU and the UK have used since 2023 for the Northern Ireland Protocol as amended, cosmetic products placed on the Northern Ireland market continue to follow EU Regulation 1223/2009.
This means: products for Northern Ireland are notified through CPNP (not SCPN), require a Responsible Person established in Northern Ireland or the EU, and use EU PIF format with EU prohibited-substance lists.
Qualifying Northern Ireland goods benefit from "unfettered access" to the rest of the United Kingdom, though the SCPN notification still has to be made before the product goes on the Great Britain market.
For brands selling across the UK and EU, unfettered access lets qualifying Northern Ireland goods move into Great Britain without additional approvals, and it can make it lawful to show a Northern Ireland or EU Responsible Person block on packaging destined for Great Britain, which is a question of label layout. It is not a recognition of compliance: the safety assessment, the PIF and the labeling duties are judged against GB law on their own terms, and unfettered access does not remove the two that decide market access: the Responsible Person has to be established in the UK (Northern Ireland counts as UK), and the product still has to be notified through SCPN. An EU-established RP holding only a CPNP notification does not cover Great Britain.
Verify current guidance with your UK RP because the unfettered-access specifics have exceptions.
The UK PIF and CPSR mirror the EU structure but must be formally UK-specific documents.
Article 11 of the UKCR requires the Responsible Person to maintain a PIF for each product placed on the GB market, readily accessible to OPSS for 10 years after the last batch placement.
The UK PIF must contain:
Product description. The finished product specification and formulation identification.
Cosmetic Product Safety Report (CPSR). The UK CPSR following Annex 1 architecture, covering Part A (safety information) and Part B (safety assessment conclusion), signed by a qualified safety assessor.
Manufacturing method and GMP statement. Description of the manufacturing process with a GMP compliance statement, typically referencing ISO 22716.
Proof of effect claimed. Supporting evidence for any claims made on the label, website, or advertising.
Animal testing data. Details of any animal testing conducted by the manufacturer or its suppliers on ingredients or finished product, including testing for other regulatory purposes. UK law, like EU law, prohibits animal testing for cosmetic purposes.
Language requirement. The UK PIF must be in English: the assimilated Regulation requires it, and English also satisfies most EU member state requirements for comparable EU PIFs.
A UK CPSR is structurally identical to an EU CPSR, with adjustments for UK-specific references.
The assessor must reference the Great Britain restriction limits in force (UKCR Annex 3), the Great Britain prohibited substances in force (UKCR Annex 2), and the statutory instruments that have amended these lists since Brexit.
Safety assessor qualifications under UKCR follow the EU standard: university diploma in pharmacy, toxicology, medicine, or similar discipline, or a course recognized as equivalent by the Secretary of State, which is where Schedule 34 replaced the reference to a member state. A qualified EU assessor can typically sign a UK CPSR, provided the assessor is familiar with UK-specific requirements.
Practical implication. Brands with an existing EU CPSR usually need their safety assessor to produce a UK-specific version that references UKCR rather than EU 1223/2009, reflects current Great Britain prohibited substances (which have diverged from EU lists since 2021), and applies current Great Britain ingredient concentration limits. The content overlap is high but the document must be formally separate.
For the detailed CPSR requirements and process, see the dedicated guide.
Brands selling in both markets typically operate with parallel documentation infrastructure.
Dual PIF. Two separate files, one with EU RP address and EU CPSR references, one with UK RP address and UK CPSR references. Most content elements are shared, but the files exist separately and each is held by its respective Responsible Person.
Dual notification. CPNP for EU member states plus Northern Ireland, SCPN for Great Britain.
Label variations. EU-market labels with EU RP address, Great Britain labels with UK RP address. For products physically manufactured outside the UK, country of origin declarations may require adjustment.
Update synchronization. When a formulation change or ingredient update occurs, both PIFs must be updated, both notifications updated, and label artwork for both markets refreshed. This operational discipline is the cost of dual-market compliance.
Great Britain ingredient control has diverged from EU practice since 2021, and 2026 brings the most significant set of Great Britain-specific changes yet.
UKCR Annex 2 lists substances prohibited in cosmetics. Annex 3 lists substances restricted under specific concentration limits and conditions of use. Annexes 4, 5 and 6 cover permitted colorants, preservatives, and UV filters.
Changes to these annexes happen through statutory instruments (SIs) enacted by the UK government, informed by scientific opinions from SAG-CS (the UK’s SCCS equivalent).
SAG-CS operates with a narrower remit than the EU SCCS. It reviews substances on UK government request, issues opinions that inform OPSS regulatory proposals, and publishes its findings for public comment periods before final SI adoption.
Statutory Instrument 2026 No. 23 (officially The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026) is the most significant recent UK ingredient update.
The draft was notified to the WTO on October 31, 2025, with consultation closing December 30, 2025, and the final regulations take effect in mid-2026.
Enzacamene (4-Methylbenzylidene Camphor, 4-MBC) ban. From July 15, 2026, this UV filter is prohibited in cosmetic products placed on the Great Britain market. It moves from the permitted UV filter list (UKCR Annex 6) to the prohibited substances list (Annex 2).
Sixteen additional CMR substances prohibited. Classified as CMR of category 1B or 2 under the GB CLP Regulation, these are added to UKCR Annex 2 as entries 1745 to 1760, in force August 15, 2026. 4-MBC is a separate addition, entry 1744, in force July 15, 2026, so it is not one of the sixteen: seventeen entries in total. The sixteen are Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide (TPO), Clothianidin, Dimethyl propylphosphonate, Dibutyltin maleate, and twelve more listed in the SI schedule.
Sell-through transition. Two separate windows. 4-MBC: stock placed on the Great Britain market before July 15, 2026, and compliant with the formaldehyde labeling rule in paragraph 2 of the Annex 5 Preamble as it stood before that date, may continue to be made available until the end of January 14, 2027. The sixteen CMR substances: stock placed before August 15, 2026 may continue to be made available until the end of February 14, 2027. Neither window allows further placement on the market.
Formaldehyde labeling. SI 2026/23 also tightens the labeling threshold for formaldehyde-releasing substances, bringing UK practice closer to EU requirements on this specific point.
Between 2021 and 2025, the UK enacted multiple statutory instruments updating the cosmetic annexes, typically in alignment with EU amendments but with specific UK timing and scope.
Key recent SIs include SI 2022/659, SI 2023/836, SI 2024/455, SI 2024/1334, SI 2025/413, and SI 2025/901. These covered updates to Annex III restrictions on substances including kojic acid, BHT, methyl salicylate, and specific preservatives, plus adjustments to UV filters. None of them touched Annex 4: the GB colorant list has stayed frozen at its 31 December 2020 content for the whole period, which is one of the places where a brand assuming GB follows the EU gets it wrong.
Sell-through deadlines from the earlier SIs extended into late 2025 and early 2026. Brands still selling products containing reformulation-affected substances may be using finishing sell-through windows right now.
The SI 2026/23 timing illustrates how Great Britain and EU ingredient policy is now operating.
The EU adopted Commission Regulation (EU) 2026/78 on January 12, 2026 (EU CMR Amending Instrument), updating EU Annexes II, III, IV, and V. SI 2026/23 is not the GB counterpart of it: the two instruments address different substances. The EU act deals mainly with silver as a colorant, which GB has not followed, while SI 2026/23 works on 4-MBC, a group of CMR substances and the formaldehyde threshold, in GB Annexes 2, 5 and 6, and leaves Annex 4 alone. The nearest EU equivalents of SI 2026/23 are the earlier acts on those same substances, not this one.
For brands selling in both markets, this means a single "compliance calendar" is not enough. Each market has its own timeline, and reformulation decisions must account for whichever market has the earlier or stricter deadline.
The divergence between Great Britain and the EU is gradual, not dramatic. Most Great Britain cosmetic rules still track the EU closely because there is no strategic benefit to diverging just for its own sake. But the gradual drift is real, and by 2026 it is enough that a brand cannot rely on a single EU formulation working for both markets across every product category.
Plan for incremental reformulation, not one big harmonized push. A product category that is fine today may need attention in six months based on either market’s next SI or amending instrument.
The UK compliance path has specific patterns worth flagging for brands at different stages.
Five steps in typical order.
Appoint a UK Responsible Person. Before any other UK compliance work, contract a UK RP. The brand will need the UK RP’s registered UK address for labels and notifications, so this decision precedes label finalization.
Build or adapt the UK PIF and CPSR. If the brand has an existing EU PIF and CPSR, work with the safety assessor to produce a UK-specific version. If starting from scratch, build the full UK PIF from manufacturer documentation and assessor input.
Design Great Britain labels. Great Britain labels need the UK RP address, UKCR-compliant ingredient declaration, and any Great Britain-specific declarations. Reuse EU label artwork only after specific review.
File the SCPN notification. Through the UK RP’s OPSS account, with all Article 13-equivalent information and the product label upload.
Plan for OPSS response capability. The UK RP must be able to respond to OPSS queries promptly. For brands without in-house UK regulatory capacity, the UK RP service covers this by default.
Typical timeline. For a brand with complete EU compliance in place, adding UK compliance runs 6 to 10 weeks from UK RP contract signature to SCPN-notified products. For a brand starting from zero, similar timelines to an initial EU launch (3 to 6 months) apply.
Typical budget. UK RP annual fee 500 to 2,000 GBP, UK PIF adaptation 500 to 1,500 GBP per product (less if EU PIF is complete), UK label design adjustment 300 to 800 GBP per product, SCPN filing 200 to 500 GBP per product through a service.
The operational discipline is maintaining the parallel infrastructure without letting either side drift.
Annual UK RP check. Verify your UK RP is still operating, registered, and responsive. Some service providers change structure, rebrand, or wind down, and an absent RP creates immediate compliance exposure.
Track UK statutory instruments. OPSS and CTPA (Cosmetic, Toiletry and Perfumery Association) publish current and upcoming SI information. At minimum, check quarterly for SIs affecting your formulations.
Audit SI 2026/23 exposure before July 15, 2026. If any of your formulations contain 4-MBC, reformulation must be complete before that date for new production, with existing stock sell-through ending January 14, 2027. For the sixteen prohibited CMR substances the deadline is August 15, 2026, with sell-through ending February 14, 2027.
Update SCPN notifications after reformulations. Any composition change triggers an SCPN update obligation.
Monitor the divergence between the EU and Great Britain. The lists drift apart gradually, so a substance still permitted in Great Britain may be prohibited in the EU or vice versa, and you should cross-check annually with your safety assessor.
Three patterns I see consistently in UK compliance failures.
Assuming the EU RP also covers Great Britain. This has been impossible since January 1, 2021, but the assumption persists. Products imported into GB without a UK RP are non-compliant from the first shipment.
Assuming the EU PIF automatically works for Great Britain. The content overlap is high but the document is formally separate, must reference UKCR, and must reflect the Great Britain ingredient status.
Missing the Great Britain sell-through deadlines. A formulation change to comply with an EU amendment may not align with the corresponding UK SI timeline. Products can become non-compliant in one market while still compliant in the other.
For the detailed PIF requirements, the CPSR process, and label comparison across EU, Great Britain, and US, see the dedicated guides.
Do I still need to comply with EU cosmetic rules to sell in the UK after Brexit?
No, but the UK rules are substantively similar. Since January 1, 2021, the UK Cosmetics Regulation (UKCR), retained in UK law and amended by Schedule 34 of the Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019, governs cosmetics sold in Great Britain. The UKCR retained the structure and substance of EU Regulation 1223/2009 but is now legally separate and evolves independently through UK statutory instruments. Selling in Great Britain requires a UK-based Responsible Person, a UK-specific Product Information File, an SCPN notification (not CPNP), and UK-compliant labeling with a UK RP address. Northern Ireland is a separate case: under the Windsor Framework, products placed on the Northern Ireland market continue to follow EU Regulation 1223/2009 with a Northern Ireland or EU Responsible Person and CPNP notification. A brand selling in both the EU and Great Britain operates parallel compliance infrastructure.
What is SCPN and how is it different from CPNP?
SCPN (Submit Cosmetic Product Notification) is the UK government online portal, managed by OPSS, where UK Responsible Persons notify cosmetic products before market placement in Great Britain. CPNP (Cosmetic Products Notification Portal) is the European Commission portal covering the EU 27 plus Norway, Iceland, Liechtenstein, and Northern Ireland. The two systems have the same regulatory purpose (pre-market notification plus poison centre data) and similar required information (product identification, Responsible Person, frame formulation, CMR and nanomaterial declarations, label artwork). They are operationally distinct: separate login credentials, separate reference numbers, separate databases, and separate competent authorities. A product sold in both the EU and Great Britain requires both a CPNP notification (via EU RP) and an SCPN notification (via UK RP), and one notification cannot substitute for the other. Both notifications are free of charge.
Can my EU Responsible Person also act as my UK Responsible Person?
Not for Great Britain. Since January 1, 2021, the UK and EU operate under separate regulatory frameworks. A UK Responsible Person must be established in the United Kingdom, and an EU Responsible Person must be established in an EU member state; the same entity cannot serve both roles from a single establishment, with one exception: Northern Ireland, which counts as UK for the Great Britain regime and stays inside the EU regime under the Windsor Framework. In practice, brands selling in both markets contract two distinct Responsible Person services or maintain two internal entities. Typical costs: UK RP service 500 to 2,000 GBP per year, EU RP service 500 to 2,000 euros per year for a small catalog. Both roles carry full legal accountability for their respective market; neither can delegate responsibility to the other.
How does the Windsor Framework affect cosmetic compliance?
Under the Windsor Framework, which is the name the EU and the UK have used since 2023 for the Northern Ireland Protocol as amended, cosmetic products placed on the Northern Ireland market continue to follow EU Regulation 1223/2009. This means products for Northern Ireland are notified through CPNP with a Northern Ireland or EU Responsible Person, and must comply with current EU prohibited-substance lists rather than the GB Annex 2 list where they diverge. Qualifying Northern Ireland goods benefit from "unfettered access" and move into the rest of the UK without additional approvals, and a Northern Ireland Responsible Person meeting NI law is treated as meeting most of the GB obligations, safety assessment, PIF and labeling included. Unfettered access is not a route around the GB regime, though: a Responsible Person established in the UK (and Northern Ireland counts as UK) must still notify the product through SCPN before it goes on the Great Britain market. What Northern Ireland status removes is the duplicate documentation, not the notification. Verify current guidance with your Responsible Person because Windsor Framework provisions have evolved and specific exceptions apply.
What is the UK Cosmetics Regulation SI 2026/23?
Statutory Instrument 2026 No. 23 (officially The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026) amends UKCR Annexes 2, 5 and 6 to prohibit additional substances in cosmetic products sold in Great Britain. The most significant change is the prohibition of Enzacamene (4-Methylbenzylidene Camphor, 4-MBC), a UV filter historically used in sunscreen, effective July 15, 2026. The SI also prohibits sixteen substances classified as CMR of category 1B or 2 under the GB CLP Regulation, including TPO and Clothianidin, effective August 15, 2026. Products containing 4-MBC placed on the Great Britain market before July 15, 2026 may continue to be made available until the end of January 14, 2027, provided they also met the formaldehyde labeling rule in the Annex 5 Preamble as it stood before July 15, 2026; products containing the sixteen CMR substances placed before August 15, 2026 may continue to be made available until the end of February 14, 2027. Neither window allows further placement on the market. The SI also tightens labeling requirements for formaldehyde-releasing substances. Brands with formulations containing any of these substances should complete reformulation reviews and update Product Information Files, Safety Reports, and SCPN notifications before those effective dates.
Do I need a UK CPSR if I already have an EU CPSR?
The content overlap is high but the document must be formally UK-specific. A UK CPSR is structurally identical to an EU CPSR (Annex I Part A and Part B architecture, qualified safety assessor signature) but must reference UKCR rather than EU Regulation 1223/2009, reflect the Great Britain prohibited substances in force (UKCR Annex 2, which has diverged from EU Annex II since 2021), apply the Great Britain ingredient concentration limits in force (UKCR Annex 3), and reference the UK safety assessor’s qualifications under UK-recognized standards. In most cases, the same safety assessor who produced the EU CPSR can produce the UK version with the appropriate adjustments. The UK CPSR is held in the UK PIF by the UK Responsible Person, separate from the EU PIF held by the EU Responsible Person. Typical cost for producing a UK CPSR when the EU version exists: 300 to 800 GBP per product (less than a first-time CPSR because the underlying safety data is shared).
What are the enforcement consequences of UK cosmetic non-compliance?
In Great Britain enforcement is managed by OPSS and carried out at retail and distribution level by Trading Standards officers under local authority, while in Northern Ireland the enforcement authority is the district council; both work within the penalty framework defined by the UK Cosmetic Products Enforcement Regulations 2013, which applies across the United Kingdom. Non-compliant products can be subject to improvement notices, suspension notices (which prohibit further placement on the market), withdrawal notices, recall orders, and financial penalties. Breach of the UKCR provisions listed in Schedule 4 of those Regulations is a criminal offence in its own right, not only when repeated or egregious. On summary conviction, that carries up to three months' imprisonment and, in England and Wales, an unlimited fine. A missing SCPN notification, a missing or absent UK Responsible Person, or material non-compliance with UKCR ingredient rules typically triggers immediate enforcement because these are baseline requirements verifiable on inspection. Beyond statutory enforcement, UK retailers (Boots, Superdrug, John Lewis, and major chains) and marketplaces (Amazon.co.uk, and others) conduct their own compliance verification during supplier onboarding and during routine audits. A product that fails an OPSS inspection in Great Britain typically loses marketplace and retailer access within days.
Keep reading
Complete independent guide to cosmetics import/export documentation in 2026. EU, USA, and Great Britain customs requirements, HS codes, certificates of free sale, IOSS changes, MoCRA obligations, and the operational traps that cost founders the most. From 30 years in the industry.
Complete independent guide to cosmetic brand trademark protection in 2026. EUIPO, USPTO, UKIPO, and the Madrid System compared, Nice classes 3 and 5 explained, costs and timelines. From 30 years in the industry. Not legal advice.
Complete independent comparison of cosmetic label requirements across the EU, USA, and Great Britain in 2026. Mandatory elements, symbols, language rules, printing technique constraints, and a pre-production checklist. From 30 years in the industry.
